People news

Share this article:
MANUFACTURERS
UCB
has appointed Mark McDade, executive vice president, global operations. He succeeds Bill Robinson, who will retire December 31, 2008.

Somnus Therapeutics, a private specialty pharmaceutical company focused on insomnia treatments, has announced the initial four members of its board of directors: Gary Cupit, CEO; Linda Hogan, chief business officer; David Ramsay, partner, Care Capital; and Jack Britts, president and CEO, Merz Pharmaceuticals.

AGENCIES
Media buying agency Compas has promoted Nicole Woodland-DeVan, formerly executive director, promotional purchasing, to vice president, beyond branding.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions